Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03028402 · ClinicalTrials.gov registry record

Adjacent Segment Mechanics in Cervical Arthrodesis Patients

A clinical trial of Intervertebral Disc Degeneration, sponsored by University of Pittsburgh.

Completed
Registry status
106
Enrollment target
1
Study location

NCT03028402: Completed study of Intervertebral Disc Degeneration, sponsored by University of Pittsburgh.

NCT03028402 is a study of Intervertebral Disc Degeneration that has completed, run by University of Pittsburgh. The registered enrollment target is 106 participants, below the 179-participant average among 4 other Intervertebral Disc Degeneration trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03028402, a study of Intervertebral Disc Degeneration, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
106 participants
Enrollment target
1
Study location

Study Summary

This study aims to determine to what extent patient-specific factors, iatrogenic factors, and biomechanical factors influence cervical spine mechanics after single-level and two-level arthrodesis.

Primary Outcome

range of motion (ROM) in degrees

Interventions

  • PROCEDURE C5-C6 arthrodesis

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Biodynamics Lab - Pittsburgh

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2016-04
Est. Completion 2024-12-30
University of Pittsburgh

1,238 total trials

What the finished NCT03028402 record still lists

NCT03028402 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 179-participant average among 4 other Intervertebral Disc Degeneration trials with a reported enrollment target (41% lower).

The record links to 1 condition, with Intervertebral Disc Degeneration appearing as the primary indexed condition, and to 1 intervention - of which C5-C6 arthrodesis is the first listed.

NCT03028402 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03028402 about?

NCT03028402 is a clinical study titled "Adjacent Segment Mechanics in Cervical Arthrodesis Patients". This study aims to determine to what extent patient-specific factors, iatrogenic factors, and biomechanical factors influence cervical spine mechanics after single-level and two-level arthrodesis.

What is the current status of trial NCT03028402?

This trial is currently completed. The enrollment target is 106 participants. The study started on 2016-04. Estimated completion is 2024-12-30.

What conditions does trial NCT03028402 study?

This clinical trial studies the following conditions: Intervertebral Disc Degeneration.

What interventions are being tested in trial NCT03028402?

The interventions under investigation include: C5-C6 arthrodesis (PROCEDURE).

Who is sponsoring clinical trial NCT03028402?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03028402 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intervertebral Disc Degeneration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03028402, the US trial registry maintained by the National Library of Medicine. NCT03028402 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.